| |
 |
|
| | |
Discussion forum - BSH 2020 VIRTUAL
 Topic - Myeloma
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER. |
|
|
| | |
|
|
|
|
Poster: 124
Visits: 67
Title: INSIGHT MM Study Of Routine Clinical Practice In Multiple Myeloma: Analysis Of Duration Of Therapy And Treatment Sequencing In UK Patients
Authors: Gordon Cook , 1. Gordon Cook, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, UK;
2. John Ashcroft, Mid Yorkshire Hospitals NHS Foundation Trust, Wakefield, UK;
3. Kevin Boyd, The Royal Marsden NHS Foundation Trust, London, UK;
4. Mamta Garg, Department of Haematology, University Hospitals of Leicester NHS Trust, Leicester, UK;
5. Rachel Hall, Royal Bournemouth Hospital NHS Foundation Trust, Bournemouth, UK;
6. Bhuvan Kishore, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK;
7. Sally Moore, Royal United Hospitals, Bath NHS Foundation Trust, Bath, UK;
8. Dean Smith, Nottingham University Hospitals NHS Trust, Nottingham, UK;
9. Nicola Crofts, Takeda UK Limited, High Wycombe, UK;
10. Kaili Ren, Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;
11. Guy Pratt, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Centre:
|
|
You must be registered to reply or comment.
|
|
INSIGHT MM STUDY OF ROUTINE CLINICAL PRACTICE IN MULTIPLE MYELOMA: ANALYSIS OF DURATION OF THERAPY AND TREATMENT SEQUENCING IN UK PATIENTS
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 1
Visits: 536
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre:
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 103
Visits: 131
Title: Lenalidomide with Low-Dose Dexamethasone in Newly DiagnosedTransplant-Ineligible Myeloma. Real-World Experience: Data from a SingleCentre in North Wales, United Kingdom.
Authors: Chaminda Arachchilage , Chaminda Arachchilage:Hematology,GLAN CLWYD HOSPITAL,Rhyl,United Kingdom|Earnest Heartin:Hematology,GLAN CLWYD HOSPITAL,Rhyl,United Kingdom|Christopher Smith:Hematology,GLAN CLWYD HOSPITAL,Rhyl,Unite
Centre:
|
|
|
|
